MONTESARCHIO, DANIELA
 Distribuzione geografica
Continente #
NA - Nord America 9.805
AS - Asia 9.762
EU - Europa 7.495
SA - Sud America 1.289
Continente sconosciuto - Info sul continente non disponibili 361
AF - Africa 261
OC - Oceania 25
AN - Antartide 1
Totale 28.999
Nazione #
US - Stati Uniti d'America 9.393
SG - Singapore 4.396
RU - Federazione Russa 3.004
IT - Italia 1.872
VN - Vietnam 1.797
CN - Cina 1.774
BR - Brasile 1.042
HK - Hong Kong 750
DE - Germania 528
FR - Francia 335
FI - Finlandia 298
UA - Ucraina 270
IE - Irlanda 267
CA - Canada 248
NL - Olanda 230
GB - Regno Unito 213
BD - Bangladesh 184
SE - Svezia 177
JP - Giappone 174
IN - India 153
AR - Argentina 105
MX - Messico 77
ZA - Sudafrica 74
TR - Turchia 72
ES - Italia 67
CI - Costa d'Avorio 66
PL - Polonia 59
KR - Corea 56
IQ - Iraq 50
TH - Thailandia 48
PH - Filippine 46
ID - Indonesia 42
PK - Pakistan 35
EC - Ecuador 34
CO - Colombia 32
MA - Marocco 30
BE - Belgio 25
TW - Taiwan 25
CZ - Repubblica Ceca 24
LT - Lituania 22
AU - Australia 21
UZ - Uzbekistan 19
VE - Venezuela 18
DZ - Algeria 16
PY - Paraguay 16
AT - Austria 15
CR - Costa Rica 15
IR - Iran 14
CL - Cile 13
JO - Giordania 13
NP - Nepal 13
SA - Arabia Saudita 13
AE - Emirati Arabi Uniti 12
EG - Egitto 11
MY - Malesia 11
HN - Honduras 10
JM - Giamaica 10
KE - Kenya 9
NI - Nicaragua 9
PE - Perù 9
PT - Portogallo 9
TN - Tunisia 9
BG - Bulgaria 8
UY - Uruguay 8
DK - Danimarca 7
GR - Grecia 7
IL - Israele 7
KZ - Kazakistan 7
LB - Libano 7
RO - Romania 7
TT - Trinidad e Tobago 7
BH - Bahrain 6
HU - Ungheria 6
AL - Albania 5
BO - Bolivia 5
BW - Botswana 5
CH - Svizzera 5
DO - Repubblica Dominicana 5
EE - Estonia 5
LA - Repubblica Popolare Democratica del Laos 5
NO - Norvegia 5
OM - Oman 5
AZ - Azerbaigian 4
BB - Barbados 4
CU - Cuba 4
LC - Santa Lucia 4
LY - Libia 4
PR - Porto Rico 4
PS - Palestinian Territory 4
BY - Bielorussia 3
CG - Congo 3
EU - Europa 3
GF - Guiana Francese 3
HR - Croazia 3
KG - Kirghizistan 3
MD - Moldavia 3
MN - Mongolia 3
NZ - Nuova Zelanda 3
SI - Slovenia 3
SN - Senegal 3
Totale 28.562
Città #
Singapore 2.003
San Jose 1.384
Chandler 871
Moscow 753
Hong Kong 719
Ashburn 706
Beijing 528
Ho Chi Minh City 490
Hanoi 423
Napoli 345
Santa Clara 338
Naples 327
Jacksonville 259
The Dalles 257
Los Angeles 250
Millbury 248
Council Bluffs 241
Lauterbourg 233
Princeton 209
Amsterdam 198
Hefei 179
Nanjing 170
Houston 157
Boston 153
Tokyo 135
Munich 131
Ottawa 128
Woodbridge 128
Buffalo 123
New York 118
Dallas 106
Milan 106
São Paulo 101
Hamburg 91
Wilmington 91
Phoenix 82
Redondo Beach 78
Rome 76
Da Nang 71
Haiphong 67
Des Moines 65
Dong Ket 60
Ann Arbor 54
Seattle 51
Brooklyn 49
Orem 49
Warsaw 48
Helsinki 46
Chicago 43
Montreal 43
Turku 42
Denver 41
Lawrence 41
Atlanta 40
Jiaxing 40
Johannesburg 40
Nanchang 39
Frankfurt am Main 38
Mexico City 38
Hebei 37
London 37
Rio de Janeiro 37
Shenyang 35
Toronto 33
Biên Hòa 32
Norwalk 32
Tianjin 30
Changsha 29
Dublin 29
Falls Church 29
Belo Horizonte 27
Seoul 27
Düsseldorf 26
Redwood City 26
San Francisco 26
Boardman 25
Can Tho 25
Chennai 25
Manchester 25
Chengdu 24
Cagliari 23
Nuremberg 23
Stockholm 23
Madrid 22
Augusta 21
Hải Dương 21
Dhaka 20
Falkenstein 20
Indiana 20
Salerno 20
Brno 19
Bangkok 18
Charlotte 18
Curitiba 18
Kronberg 18
Pune 18
Guangzhou 17
Brasília 16
Sydney 16
Thái Bình 16
Totale 14.943
Nome #
Nanoparticelle ibride magnetite-oro con struttura nucleo-guscio funzionalizzate 349
CyPLOS, a new family of synthetic ion transporters 206
Anti-HIV activity of new higher order G-quadruplex aptamers obtained from tetra-end-linked oligonucleotides 200
Functionalized hybrid magnetite gold nanoparticles with core-shell structure 199
Tandem application of ligand-based virtual screening and G4-OAS assay to identify novel G-quadruplex-targeting chemotypes 181
BENZODIFURAN DERIVATIVES AS POTENTIAL ANTIPROLIFERATIVE AGENTS: POSSIBLE CORRELATION BETWEEN THE BIOACTIVITY AND THEIR AGGREGATION PROPERTIES 181
Incontri di parole: dal sapere al comprendere, al sentire e viceversa "INCROCI DI PAROLE". 180
"dressing up" an Old Drug: An Aminoacyl Lipid for the Functionalization of Ru(III)-Based Anticancer Agents 172
Incontri di parole: dal sapere al comprendere, al sentire e viceversa "BELLEZZA". 170
Antiproliferative effects of ruthenium-based nucleolipidic nanoaggregates in human models of breast cancer in vitro: insights into their mode of action. 168
Exploring cellular uptake, accumulation and mechanism of action of a cationic Ru-based nanosystem in human preclinical models of breast cancer 167
Incontri di parole: dal sapere al comprendere, al sentire e viceversa "VEDERE". 163
Fluorescence enhancement in G-quadruplex folding: synthesis, structure and stability of a novel dansyl-tagged, conjugated TBA 163
Stability is not everything the case of the cyclization of the thrombin binding aptamer 162
Relazione struttura-stabilita' di quadruple eliche di DNA con attivita' anti-HIV 158
Breast cancer chemotherapeutic options: a general overview on the preclinical validation of a multi-target ruthenium(III) complex lodged in nucleolipid nanosystems 157
Incontri di parole: dal sapere al comprendere, al sentire e viceversa "GENERE". 152
Anticancer activity of a cationic Ru-based nanosystem in a human xenograft model of breast cancer 152
Solid phase synthesis of DNA-3'-PNA chimeras by using Bhoc/Fmoc PNA monomers 151
Shedding light on the interaction of polydatin and resveratrol with G-quadruplex and duplex DNA: a biophysical, computational and biological approach 151
Ru(III) complexes for anticancer therapy: the importance of being nucleolipidic 149
Ruthenium-based nanovectors for cancer therapy 149
Interplay of crystallography, Raman microspectroscopy and electrospray mass spectrometry for studying the reaction between ruthenium complexes and proteins 149
Huntingtin protein: A new option for fixing the Huntington's disease countdown clock 149
On the pH-Modulated Ru-Based Prodrug Activation Mechanism 149
1-Substituted 2’-deoxyinosine analogues 147
Lipooligosaccharides as Amphiphiles to Build Liposomes for Effective Drug Delivery: The Case of Anticancer Ruthenium Complex-Based Aggregates 147
A new solid support for the synthesis of oligonucleotide-tetraphenylporphyrin conjugates 146
Interference of polydatin/resveratrol in the ACE2:Spike recognition during COVID-19 infection. a focus on their potential mechanism of action through computational and biochemical assays 145
Preclinical validation of an original Ru(III)-based nanosystem in human models of breast cancer 144
Fighting the Huntington’s Disease with a G-Quadruplex-Forming Aptamer Specifically Binding to Mutant Huntingtin Protein: Biophysical Characterization, In Vitro and In Vivo Studies 144
A novel dansyl-labelled TBA15 analog showing fluorescence enhancement upon G-quadruplex formation for early detection of thrombin 142
Fluorescence Sensing Using DNA Aptamers in Cancer Research and Clinical Diagnostics 142
Tailoring a lead-like compound targeting multiple G-quadruplex structures 142
On the binding of naphthalene diimides to a human telomeric G-quadruplex multimer model 142
Synthesis and NMR characterization of a novel crown ether ring-fused uridine analogue 141
Fluorescence enhancement in G-quadruplex folding: Synthesis, structure and stability of a novel dansyl-tagged, conjugated TBA 141
Bioengineered lipophilic Ru(III) complexes as potential anticancer agents 140
SOLID PHASE SYNTHESIS OF OLIGONUCLEOTIDES TETHERED TO OLIGO-GLUCOSE PHOSPHATE TAILS 140
Insights into the G-rich VEGF-binding aptamer V7t1: when two G-quadruplexes are better than one! 140
Nucleolipidic-based liposomes effectively deliver a Ru(III) complex across cell membranes to nuclei promoting in concert apoptosis and autophagy in human models of breast cancer 140
Exploring the conformational behaviour and aggregation properties of lipid-conjugated AS1411 aptamers 140
A New Competitive Fluorescence Assay for the detection of Patulin Toxin 139
Incontri di parole: dal sapere al comprendere, al sentire e viceversa "CASO". 139
G-quadruplex-based aptamers against protein targets in therapy and diagnostics 139
Truncated Analogues of a G-Quadruplex-Forming Aptamer Targeting Mutant Huntingtin: Shorter Is Better! 138
Innovation and Perspectives in Solid Phase Synthesis & Combinatorial Libraries 138
Dna binding mode analysis of a core-extended naphthalene diimide as a conformation-sensitive fluorescent probe of g-quadruplex structures 138
A first-in-class and a fished out anticancer platinum compound:: Cis -[PtCl2(NH3)2] and cis -[PtI2(NH3)2] compared for their reactivity towards DNA model systems 136
Amphiphilic nucleoside complexes of ruthenium (III): a novel strategy in anticancer research 134
Directing in Vitro Selection towards G‐quadruplex‐forming Aptamers to Inhibit HMGB1 Pathological Activity 133
Cationic liposomes as efficient nanocarriers for the drug delivery of an anticancer cholesterol-based ruthenium complex 133
A terminal functionalization strategy reveals unusual binding abilities of anti-thrombin anticoagulant aptamers 131
6-Chloroxanthosine as useful intermediate for efficient syntheses of [6-15N]-isoguanosine, isoinosine and other purine nucleoside analogues 131
Design, Synthesis and Characterisation of novel amphiphilic guanosine derivatives 131
A new fluorescent TBA for early detection of thrombin: A biophysical study 131
Exploring cellular uptake, accumulation and mechanism of action of an anticancer Ru(III) complex loaded into a nucleolipidic-based nanosystem in preclinical models of human breast cancer 131
Synthesis and biophysical characterization of G-rich oligonucleotides conjugated with sugar-phosphate tails 129
Tuning the polymorphism of the anti-VEGF G-rich V7t1 aptamer by covalent dimeric constructs 129
Phosphocholine-decorated superparamagnetic iron oxide nanoparticles: defining the structure and probing in vivo applications 128
Benzodifurans for biomedical applications: BZ4, a selective anti-proliferative and anti-amyloid lead compound 128
The role of G-quadruplex structures of LIGS-generated aptamers R1.2 and R1.3 in IgM specific recognition 128
B-Amino acid residues: Conformational characterization of an N- and C-protected homo-B-(S)-leucine 127
A new ferrocenemethyl-thymidine nucleoside: Synthesis, incorporation into oligonucleotides and optical spectroscopic studies on the resulting single strand, duplex and triplex structures 127
A new synthetic strategy for the prepartion of glyco-peptide conjugates 127
Solid phase approach to the preparation of small circular DNA and RNA fragments 126
CyPLOS, novel carbohydrate-based synthetic ion transporters 126
Nucleolipidic-based Ru(III) nanosystems induce multiple cell death pathways activation in preclinical models of human breast cancer 126
Design, synthesis and characterization of a fluorescently labelled CyPLOS ionophore 125
IV Convegno "Donne nella Scienza" 125
Developing functionalized Fe3O4-Au nanoparticles: A physico-chemical insight 125
Synthesis, DNA binding studies, and antiproliferative activity of novel Pt(II)-complexes with an L-alanyl-based ligand 125
G-Quadruplex Forming Oligonucleotides as Anti-HIV Agents 124
Insights into the Small Molecule Targeting of Biologically Relevant G-Quadruplexes: An Overview of NMR and Crystal Structures 123
Nanostructuring of CyPLOS (Cyclic Phosphate-Linked OligoSaccharides), novel saccharide-based ion transporters 123
5'-Modified G-quadruplex forming oligonucleotides endowed with anti-HIV activity: synthesis and biophysical properties 123
Guanosine-based amphiphiles: synthesis, biophysical characterization and biological activity 123
2-(Phenylthio)-ethyl as a novel two-stage base protecting group for thymine analogues 122
A facile solid-phase syntesis of oligonucleotides containing a 3’-3’ phosphodiester bond for alternate strand triple-helix formation 122
A new solid-phase synthesis of oligonucleotides 3’-conjugated with peptides 122
Antitumour activity of resveratrol on human melanoma cells: A possible mechanism related to its interaction with malignant cell telomerase 122
Anti-VEGF DNA-based aptamers in cancer therapeutics and diagnostics 122
Method for the preparation of a low unspecific binding-support for affinity chromatography and/or on-line synthesis of oligonucleotides 122
Towards an analytical methodology for the screening of G-quadruplex-binding ligands 121
Fluorescent Thrombin Binding Aptamer-Tagged Nanoparticles for an Efficient and Reversible Control of Thrombin Activity 121
On the interaction of an anticancer trisubstituted naphthalene diimide with G-quadruplexes of different topologies: a structural insight 121
Tesi di dottorato in Scienze Chimiche: SINTESI DI NUCLEOSIDI E NUCLEOTIDI MODIFICATI 120
CyPLOS: a new family of synthetic ionophores 120
Controlled Pore Glass-based oligonucleotide affinity support: towards High Throughput Screening methods for the identification of conformation-selective G-quadruplex ligands 120
Disentangling the Structure-Activity Relationships of Naphthalene Diimides as Anticancer G-Quadruplex-Targeting Drugs 120
Design, Synthesis and Characterization of novel amphiphilic Guanosine-based Nucleolipids 119
Fully automated synthesis of peptide-oligonucleotide conjugates 119
Metodo per la preparazione di un supporto a basso legame aspecifico per cromatografia di affinità e/o sintesi diretta di oligonucleotidi 119
Safety and efficacy evaluation in vivo of a cationic nucleolipid nanosystem for the nanodelivery of a ruthenium(III) complex with superior anticancer bioactivity 119
CYCLIC URIDINE DIPHOSPHATE GLUCOSE, A NEW PYRIMIDINE ANALOG OF CYCLIC ADP RIBOSE 118
Solid Phase Synthesis of cyclic PNA and PNA-DNA chimeras 118
A new design for nucleolipid-based Ru(III) complexes as anticancer agents 118
In vitro bioactivity of ruthenium-based multifunctional nucleolipidic liposomes: new promising agents for cancer therapy 118
Triple Negative Breast Cancer Preclinical Therapeutic Management by a Cationic Ruthenium-Based Nucleolipid Nanosystem 118
On the compatibility of azides in phosphoramidite-based couplings: synthesis of a novel, convertible azido-functionalized CyPLOS analogue. 117
Totale 14.047
Categoria #
all - tutte 97.643
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 97.643


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.356 0 0 15 34 7 87 18 43 279 65 244 564
2022/20232.058 273 168 43 200 225 229 21 190 349 218 109 33
2023/20241.197 53 221 141 76 54 111 53 130 16 16 212 114
2024/20256.972 357 453 40 106 139 355 729 456 548 657 2.477 655
2025/202612.771 1.360 894 1.377 1.198 2.400 486 1.327 774 1.530 856 279 290
2026/20271.053 222 562 269 0 0 0 0 0 0 0 0 0
Totale 28.999